The Joint Corp. · NASDAQ:JYNT

The Joint — Q1 2023 Earnings Presentation

15 slides from The Joint's earnings presentation, May 4, 2023

  1. Slide 1: Q1 2023 Financial Results

    The Joint Corp. | NASDAQ: JYNT | thejoint.com Q1 2023 Financial Results As of March 31, 2023 | Reported on May 4, 2023

  2. Slide 2: Safe Harbor Statements

    Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements” about future events and expectations. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our

  3. Slide 3: Three Enterprise Initiatives to Advance Growth

    Three Enterprise Initiatives to Advance Growth Forging the Harnessing the Accelerating the Chiropractic Power of Pace of Dream Our Data Clinic Growth © 2023 The Joint Corp. All Rights Reserved. 3

  4. Slide 4: Building upon Foundation for Growth

    Building upon Foundation for Growth Q1 2023 Q1 2022 Revenue $28.5M $22.4M 17% 8% 1% Operating Loss $678K $176K Increase in Increase in Increase in Other system-wide sales comp sales1 for all clinics comp sales1 for all clinics $3.8M $(16)K Q1 2023 over Q1 2022 >13 months in operation Income/(Expense

  5. Slide 5: 33 New Clinics in Q1 2023, Up from 31 in Q1 2022

    33 New Clinics in Q1 2023, Q1 2023 Q1 2022 Up from 31 in Q1 2022 TOTAL CLINICS OPEN Franchise Licenses Sold 17 22 Franchise Company Owned/Managed 126 130 Total New 96 Franchised 29 27 64 Clinics Opened 60 48 Greenfield Clinics Opened 4 4 61 47 712 740 47 610 4 515 453 394 Franchised 352 Clinics Acqu

  6. Slide 6: Pipeline for Growth

    Pipeline for Growth Franchise Licenses Sold Annually Clinics in Active Development1 Gross Cumulative Franchise Licenses Sold1 283 1193 1210 156 253 1118 235 218 962 126 121 204 841 99 715 155 616 75 112 37 17 Dec. 31, Dec. 31, Dec. 31, Dec. 31, Dec. 31, Dec. 31, Mar. 31, Dec. 31, Dec. 31, Dec. 31, D

  7. Slide 7: Enhancing Marketing Programs

    Enhancing Marketing Programs “Love The Joint” Social Campaign Sweepstakes • 14,900+ entries and comments • 20,000+ likes • 13,000+ new followers Annual New Patient Contest • Promote $29 new patient offer • 19% new patient increase in March over prior three-month average © 2023 The Joint Corp. All Ri

  8. Slide 8: Q1 2023 Financial Results

    Q1 2023 Financial Results $ in M1 Q1 2023 Q1 2022 Differences Revenue $28.5 $22.4 $6.0 27% • Corporate clinics 17.1 12.6 4.5 36% • Franchise fees 11.3 9.8 1.5 15% Cost of revenue 2.6 2.3 0.3 8% Sales and marketing 4.1 3.3 0.9 27% Depreciation and amortization 2.3 1.6 0.7 44% G&A 19.9 15.4 4.5 30% Op

  9. Slide 9: Reiterating 2023 Financial Guidance

    Reiterating 2023 Financial Guidance 2022 2023 Low 2023 High $ in M Actual Guidance Guidance Revenues $101.9 $123.0 $128.0 Adjusted EBITDA1 $11.5 $12.5 $14.0 New Franchised Clinic Openings 121 100 120 New Greenfield Clinics2 16 8 12 1 Reconciliation of Adjusted EBITDA to GAAP earnings is included in

  10. Slide 10: Leading Market Growth

    Leading Market Growth The Joint Corp. 12-yr. CAGR 62%1 vs. Industry 5-yr. CAGR 5.1%2 System-wide Sales People will ($ in M) continue to seek more noninvasive, $435.3 holistic ways to 62% CAGR1 $361.1 manage their pain. (2010 - 2022) $260.0 $220.3 We’ll be there to treat them. $126.9 $165.1 $115.4 $9

  11. Slide 11: Driving Long-term Shareholder Value

    Driving Long-term Shareholder Value The most powerful brand-building tool is our storefronts. © 2023 The Joint Corp. All Rights Reserved. 11

  12. Slide 12: Performance Metrics and Non-GAAP Measures

    Performance Metrics and Non-GAAP Measures This presentation includes commonly discussed performance metrics. System-wide sales include sales at all clinics, whether operated by the company or by franchisees. While franchised sales are not recorded as revenues by the company, management believes the

  13. Slide 13: Q1 2023 Segment Results as of Mar. 31, 2023

    Q1 2023 Segment Results as of Mar. 31, 2023 $ in 000s Q1 2023 © 2023 © 2022 The The Joint Joint Corp. Corp. All All Rights Rights Reserved. Reserved. 13

  14. Slide 14: GAAP – Non-GAAP Reconciliation

    GAAP – Non-GAAP Reconciliation $ in 000s © 2023 The Joint Corp. All Rights Reserved. 14

  15. Slide 15: Contact Information

    Contact Information Peter D. Holt, President & CEO peter.holt@thejoint.com The Joint Corp. | 16767 N. Perimeter Dr., Suite 110, Scottsdale, AZ 85260 | (480) 245-5960 https://www.facebook.com/thejointchiro @thejointchiro Jake Singleton, CFO jake.singleton@thejoint.com https://twitter.com/thejointchir

The Joint — Q1 2023 Earnings Presentation on 6ix